Cervical cancer screening intervals could be extended to five years for women aged 30 and over if the primary screening method was human papillomavirus (HPV) testing, say scientists at Queen Mary, University of London.
The research, published in the British Journal of Cancer today (28 April), found HPV tests are very accurate in identifying early signs of cervical cancer, detecting more serious abnormalities compared to current cytology screening in women aged 30 and over.